Review decisions

Showing 160 results of 292 total
Summary Safety Review - AUBAGIO (teriflunomide) - Assessing the potential risk of inflammation of the colon (colitis)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00167
Issued / Original Publication Date: 2017-06-28
Summary Safety Review - BRILINTA (ticagrelor) - Assessing the Potential Risk of Severe Skin Side Effects
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00166
Issued / Original Publication Date: 2017-06-26
Summary Safety Review - Finasteride - Assessing the Potential Risk of Serious Muscle-Related Side Effects
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00164
Issued / Original Publication Date: 2017-06-22
Summary Safety Review - TYSABRI (natalizumab) - Blood (hematological) Abnormalities in Newborns whose Mothers were treated with Tysabri During Pregnancy
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00165
Issued / Original Publication Date: 2017-06-22
Summary Safety Review - TECFIDERA - Assessing the Potential Risk of Kidney Injury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00162
Issued / Original Publication Date: 2017-06-15
Updated Date: 2017-06-30
Summary Safety Review - Dipeptidylpeptidase-4 (DPP-4) Inhibitors - Assessing the Potential Risk of Heart Failure
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00163
Issued / Original Publication Date: 2017-06-15
Summary Safety Review - Mefloquine - Assessing the potential risk of rare long-lasting and permanent adverse events related to the brain and nervous system (neurological) and mental health (psychiatric)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00161
Issued / Original Publication Date: 2017-06-01
Summary Safety Review - XALKORI (crizotinib) - Assessing the potential risk of developing a hole in the bowel (gastrointestinal perforation)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00160
Issued / Original Publication Date: 2017-05-04
Summary Safety Review - Ear and Forehead (contact) Infrared Thermometers (various brands) - Assessing the potential risk of inaccuracy in children under 2 years old
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00159
Issued / Original Publication Date: 2017-05-03
Summary Safety Review - Direct-Acting Antivirals - Assessing the Potential Risk of Liver Cancer Recurrence
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00157
Issued / Original Publication Date: 2017-04-27

Displaying 151 - 160 of 292 | Page 16 of 30
Report a problem or mistake on this page
Please select all that apply:
Date modified: